Literature DB >> 30948393

Chronic non-granulomatous supraglottitis of a male adolescent and its successful management with azathioprine.

Aaron Kovacs1, Shankar Haran1, Paul Paddle1.   

Abstract

Chronic non-granulomatous supraglottitis (CNGS) is a rare disorder of the supraglottic larynx, characterised by chronic supraglottic inflammation in the absence of granulomata, vasculitis, neoplasia, autoimmune disease or infective changes on histology. We present the case of a male adolescentwho attended with progressively worsening exertional dyspnoea, stridor and symptoms of obstructive sleep apnoea. Flexible nasendoscopy revealed marked supraglottic subepithelial thickening sparing the glottis and subglottis, confirmed on microlaryngoscopy. MRI of the head and neck demonstrated diffuse, homogenous supraglottic oedema. At the peak of his symptomology, the patient was admitted for further investigations and intravenous steroid therapy, and switched to prolonged oral steroids on discharge. Tracheostomy was avoided. After 3 months, he was successfully weaned from steroids to azathioprine with gradual symptomatic improvement. This case represents the first successful use of a steroid-sparing agent in the management of CNGS. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ear, nose and throat; otolaryngology / ENT

Mesh:

Substances:

Year:  2019        PMID: 30948393      PMCID: PMC6453303          DOI: 10.1136/bcr-2018-227458

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

2.  [Unusual chronic epiglottis inflammation].

Authors:  M SCHROTTENBAUM
Journal:  Zentralbl Allg Pathol       Date:  1963-04-30

3.  Azathioprine: old drug, new actions.

Authors:  Jonathan S Maltzman; Gary A Koretzky
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  Chronic nongranulomatous epiglottitis.

Authors:  M Friedman; D M Toriumi; T Strorigl
Journal:  Ear Nose Throat J       Date:  1988-07       Impact factor: 1.697

5.  Medical and surgical aspects of the granulomatous diseases of the larynx.

Authors:  D D Caldarelli; S A Friedberg; A A Harris
Journal:  Otolaryngol Clin North Am       Date:  1979-11       Impact factor: 3.346

6.  Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects.

Authors:  E V Avallone; R Pica; C Cassieri; M Zippi; P Paoluzi; P Vernia
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

7.  Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends.

Authors:  Rahul K Shah; David W Roberson; Dwight T Jones
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

8.  High-dose azathioprine in children with inflammatory bowel disease.

Authors:  D Fuentes; F Torrente; S Keady; K Thirrupathy; M A Thomson; J A Walker-Smith; S H Murch; R B Heuschkel
Journal:  Aliment Pharmacol Ther       Date:  2003-04-01       Impact factor: 8.171

9.  Hydroxychloroquine as treatment for inflammatory subglottic stenosis: a second successful case.

Authors:  G Desuter; A Gregoire; Q Gardiner; F Houssiau
Journal:  Case Rep Otolaryngol       Date:  2012-11-06

Review 10.  Steroid injection in chronic inflammatory vocal fold disorders, literature review.

Authors:  Andrea Maria Campagnolo; Domingos Hiroshi Tsuji; Luís Ubirajara Sennes; Rui Imamura
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
View more
  1 in total

1.  Omega-shaped epiglottis: a challenge.

Authors:  Joana Veiga; Cristina Gomes
Journal:  Braz J Anesthesiol       Date:  2021-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.